Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

18. May 2021 - 0:00 (CEST)

Epigenomics AG successfully completes capital increase

Read more

27. April 2021 - 0:00 (CEST)

Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders

Read more

25. March 2021 - 0:00 (CEST)

Epigenomics AG is Evaluating M&A Options

Read more

Press releases

07. October 2021

Epigenomics AG: EVP of Finance Albert Weber leaves the Company

Read more

13. September 2021

Epigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 million

Read more

02. September 2021

New study in the BMC Cancer journal shows that Epi proColon(R) is an effective method to increase CRC screening rates in medically underserved populations

Read more